Literature DB >> 20454966

Photodynamic therapy for focal ablation of the prostate.

Nimalan Arumainayagam1, C M Moore, Hashim U Ahmed, M Emberton.   

Abstract

Although in early stages of clinical development, photodynamic therapy (PDT) shows promise in delivering focal treatment of both primary and post-radiotherapy prostate cancer. This article will review the mechanism of action of PDT, previous research using PDT for treating prostate cancer including the development of newer vascular-acting photosensitizers, and the potential advantages and disadvantages of PDT in delivering focal therapy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20454966     DOI： 10.1007/s00345-010-0554-2

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


  24 in total

Review 1.  Targeted photodynamic therapy via receptor mediated delivery systems.

Authors:  Wesley M Sharman; Johan E van Lier; Cynthia M Allen
Journal:  Adv Drug Deliv Rev       Date:  2004-01-13       Impact factor: 15.470

2.  Towards accurate in vivo spectroscopy of the human prostate.

Authors:  Tomas Svensson; Erik Alerstam; Margrét Einarsdóttír; Katarina Svanberg; Stefan Andersson-Engels
Journal:  J Biophotonics       Date:  2008-08       Impact factor: 3.207

3.  Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.

Authors:  S C Chang; G Buonaccorsi; A MacRobert; S G Bown
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

4.  Photodynamic therapy in the canine prostate using motexafin lutetium.

Authors:  R A Hsi; A Kapatkin; J Strandberg; T Zhu; T Vulcan; M Solonenko; C Rodriguez; J Chang; M Saunders; N Mason; S Hahn
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

5.  Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid.

Authors:  Alison Curnow; Alexander J MacRobert; Stephen G Bown
Journal:  Lasers Surg Med       Date:  2006-04       Impact factor: 4.025

6.  Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.

Authors:  S H Selman; D Albrecht; R W Keck; P Brennan; S Kondo
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

7.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Authors:  Timothy R Nathan; Douglas E Whitelaw; Stanley C Chang; William R Lees; Paul M Ripley; Heather Payne; Linda Jones; M Constance Parkinson; Mark Emberton; Alison R Gillams; Anthony R Mundy; Stephen G Bown
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

8.  Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.

Authors:  J Trachtenberg; A Bogaards; R A Weersink; M A Haider; A Evans; S A McCluskey; A Scherz; M R Gertner; C Yue; S Appu; A Aprikian; J Savard; B C Wilson; M Elhilali
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

9.  Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide.

Authors:  Masoom A Haider; Sean R H Davidson; Ashwini V Kale; Robert A Weersink; Andrew J Evans; Ants Toi; Mark R Gertner; Arjen Bogaards; Brian C Wilson; Joseph L Chin; Mostafa Elhilali; John Trachtenberg
Journal:  Radiology       Date:  2007-05-16       Impact factor: 11.105

10.  Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer.

Authors:  P-J Lou; H R Jäger; L Jones; T Theodossy; S G Bown; C Hopper
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640
View more
  16 in total

1.  Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.

Authors:  Amar U Kishan; Sang J Park; Christopher R King; Kristofer Roberts; Patrick A Kupelian; Michael L Steinberg; Mitchell Kamrava
Journal:  Br J Radiol       Date:  2015-10-14       Impact factor: 3.039

2.  Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.

Authors:  Jonathan M Fahey; Albert W Girotti
Journal:  Nitric Oxide       Date:  2015-06-09       Impact factor: 4.427

3.  Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population.

Authors:  Yasuhiro Hashimoto; Akiko Okamoto; Atsushi Imai; Tohru Yoneyama; Shingo Hatakeyama; Takahiro Yoneyama; Takuya Koie; Noritaka Kaminura; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2011-06-16       Impact factor: 3.402

Review 4.  Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.

Authors:  Andrzej M Bugaj
Journal:  World J Methodol       Date:  2016-03-26

5.  Focal therapy for prostate cancer - where are we in 2011?

Authors:  Michael S Borofsky; Timothy Ito; Andrew B Rosenkrantz; Samir S Taneja
Journal:  Ther Adv Urol       Date:  2011-08

Review 6.  Focal therapy in prostate cancer: modalities, findings and future considerations.

Authors:  Uri Lindner; John Trachtenberg; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-09-14       Impact factor: 14.432

7.  Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience.

Authors:  Ted Lee; Neil Mendhiratta; Dan Sperling; Herbert Lepor
Journal:  Rev Urol       Date:  2014

Review 8.  Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?

Authors:  Sherri A McFarland; Arkady Mandel; Roger Dumoulin-White; Gilles Gasser
Journal:  Curr Opin Chem Biol       Date:  2019-11-20       Impact factor: 8.822

9.  Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer.

Authors:  Caroline Eymerit-Morin; Merzouka Zidane; Souhil Lebdai; Stéphane Triau; Abdel Rahmene Azzouzi; Marie-Christine Rousselet
Journal:  Virchows Arch       Date:  2013-08-16       Impact factor: 4.064

10.  Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.

Authors:  Samir S Taneja; James Bennett; Jonathan Coleman; Robert Grubb; Gerald Andriole; Robert E Reiter; Leonard Marks; Abdel-Rahmene Azzouzi; Mark Emberton
Journal:  J Urol       Date:  2016-06-09       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.